BTAI: BioXcel Therapeutics, Inc. Stock

by  •  • Comments Off on BTAI: BioXcel Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 95.18
Enterprise Value ($M) 130.56
Book Value ($M) -40.61
Book Value / Share -1.10
Price / Book -2.34
NCAV ($M) -58.07
NCAV / Share -1.57
Price / NCAV -1.64

Profitability (mra)
Return on Invested Capital (ROIC) -2.95
Return on Assets (ROA) -0.99
Return on Equity (ROE) -2.33

Liquidity (mrq)
Quick Ratio 2.57
Current Ratio 2.65

Balance Sheet (mrq) ($M)
Current Assets 72.14
Assets 73.70
Liabilities 130.21
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.38
Operating Income -167.62
Net Income -179.05
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -155.01
Cash from Investing -0.02
Cash from Financing 26.52

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-09 13G/A Fmr Llc 8.60 -6.74
02-07 13G/A Adage Capital Partners Gp, L.l.c. 1.55 -69.95
10-19 13G/A BioXcel Holdings, Inc. 30.10 0.00
10-10 13G/A FIL Ltd 9.23
09-28 13D Bioxcel Corp 32.50 -2.59

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-06 78,088 359,607 21.71
2024-05-03 17,259 136,342 12.66
2024-05-02 33,884 48,667 69.62
2024-05-01 37,987 60,275 63.02

(click for more detail)

Similar Companies
BNTC – Benitec Biopharma Inc. BON – Bon Natural Life Limited
BPTH – Bio-Path Holdings, Inc. BYSI – BeyondSpring Inc.
CALC – CalciMedica, Inc.


Financial data and stock pages provided by
Fintel.io